iiinova — where your digital self keeps evolving

Stephen Hansen @stephenhansen.bsky.social · 05/04/2025

From our 2025 #BioCentury financial markets preview: www.biocentury.com/article/654637

Stephen Hansen @stephenhansen.bsky.social · 28/03/2025

Cuts at #FDA put the agency at risk of missing PDUFA goals - from my colleague @steveusdin.bsky.social : www.biocentury.com/article/655466

020

Stephen Hansen @stephenhansen.bsky.social · 07/03/2025

#GLP1 sales continue to boom thanks to #obesity market expansion #biosky #medsky www.biocentury.com/article/655202

132

Stephen Hansen @stephenhansen.bsky.social · 28/02/2025

US consumer #inflation expectations highest since 1995. Anyone still think #tariffs don't drive inflation higher?

010

Stephen Hansen @stephenhansen.bsky.social · 26/02/2025

What's a bit crazy is most of the big surges in Fed backing for Musk's companies came in years with a Dem administration...

020

Stephen Hansen @stephenhansen.bsky.social · 14/02/2025

#WSJ op-ed: "Does Trump understand money?"

000

Stephen Hansen @stephenhansen.bsky.social · 06/02/2025

From $LLY earnings presentation today: almost all the new product growth is from #Mounjaro and #Zepbound #obesity $NVO $XBI

010

Stephen Hansen @stephenhansen.bsky.social · 03/02/2025

Re-posting this from our Biotech Markets 2025 preview story: www.biocentury.com/article/654637

000

Stephen Hansen @stephenhansen.bsky.social · 01/02/2025

From my #biotech markets preview story published the day after the inauguration: www.biocentury.com/article/654637

000

Stephen Hansen @stephenhansen.bsky.social · 31/01/2025

Two very different headlines for the same thing

000

Stephen Hansen @stephenhansen.bsky.social · 31/01/2025

@england.nhs.uk green-lights use of exa-cel to treat sickle cell disease on NHS

000

Stephen Hansen @stephenhansen.bsky.social · 30/01/2025

@gojoandgolic.bsky.social grade the presentation of the tuna sandwich lunch for my 5-year-old

020

Stephen Hansen @stephenhansen.bsky.social · 29/01/2025

One Fed employee's suggested response to Musk's resignation email:

000

Stephen Hansen @stephenhansen.bsky.social · 25/01/2025

When private #biotech raised money in 2020-22, it was often at inflated valuations that no longer match public investor expectations. So where are we in the process of the Great Biotech Valuation Reset? Our #BioCentury analysis suggests about halfway. Story here: www.biocentury.com/article/654812